Activation of the PI3K-AKT-mTOR signalling pathway is implicated in the progression of thyroid cancer [18–20], and the PI3K-AKT signalling pathway is involved in the regulation of the sialyltransferase family [11]. This evidence concerns the gene AKT1 and thyroid gland carcinoma.